Pulmonx (LUNG) Non-Current Debt (2020 - 2025)
Pulmonx's (LUNG) quarterly Non-Current Debt came in at $37.0 million in Q4 2025, up 8.78% year-on-year from $34.0 million in Q4 2024, and little changed on a QoQ basis from $37.0 million in Q3 2025.
Pulmonx (LUNG) Non-Current Debt (2020 - 2025) Analysis & Trends
Pulmonx (LUNG) has 6 years of Non-Current Debt data on file, last reported at $37.0 million in Q4 2025.
- On a quarterly basis, Non-Current Debt rose 8.78% year-over-year to $37.0 million in Q4 2025; TTM through Dec 2025 was $37.0 million, a 8.78% increase from a year earlier, with the FY2025 full-year figure at $37.0 million, up 8.78% from the prior year.
- Non-Current Debt for Q4 2025 stood at $37.0 million, roughly flat from $37.0 million in the prior quarter.
- Over the last five years, Non-Current Debt for LUNG reached as high as $37.3 million in Q1 2023 and fell as low as $179000.0 in Q4 2021.
- Historically, Non-Current Debt has averaged $24.8 million across 5 years, with a median of $34.5 million in 2023.
- Across the five-year window, Non-Current Debt plunged 68.26% in 2021 and surged 9527.93% in 2022, its largest moves.
- Year by year, Non-Current Debt stood at $179000.0 in 2021, then jumped by 9527.93% to $17.2 million in 2022, then surged by 103.6% to $35.1 million in 2023, then slipped by 3.1% to $34.0 million in 2024, then increased by 8.78% to $37.0 million in 2025.
- Per Business Quant data, the three most recent Non-Current Debt figures were $37.0 million in Q4 2025, $37.0 million in Q3 2025, and $37.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - | 36.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.99 Mn |
| Sep 30, 2025 | 37.03 Mn |
| Jun 30, 2025 | 37.12 Mn |
| Mar 31, 2025 | 29.39 Mn |
| Dec 31, 2024 | 34.00 Mn |
| Sep 30, 2024 | 37.24 Mn |
| Jun 30, 2024 | 37.11 Mn |
| Mar 31, 2024 | 37.23 Mn |
| Dec 31, 2023 | 35.09 Mn |
| Sep 30, 2023 | 37.15 Mn |
| Jun 30, 2023 | 37.15 Mn |
| Mar 31, 2023 | 37.26 Mn |
| Dec 31, 2022 | 17.23 Mn |
| Sep 30, 2022 | 12.34 Mn |
| Jun 30, 2022 | 14.46 Mn |
| Mar 31, 2022 | 16.63 Mn |
| Dec 31, 2021 | 179,000.00 |
| Sep 30, 2021 | 537,000.00 |
| Jun 30, 2021 | 544,000.00 |
| Mar 31, 2021 | 532,000.00 |